Dopaminergic dysfunction may not indicate Lewy body dementia

05/6/2013 | MolecularImaging.net

A Journal of Nuclear Medicine study that used SPECT imaging with I-123 PE21 found that binding of the tracer to the dopamine transporter system did not show a clear link with signs of Lewy body dementia. "Our results suggest that the general level of cognitive impairment in DLB patients is not influenced by striatal dopaminergic dysfunction," researchers said. However, they noted more research is needed to substantiate their findings.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX